Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
1.Miami Police Retaliate Against Female Driver Who Filmed Herself Pulling Over Cop
2.Paul Joseph Watson And Stefan Molyneux On The Real Agenda Behind The Migrant Crisis
3.Hillary Clinton Suggests She Can't Be Part Of The Establishment Because She Is A Woman
4.Texas Appeals Court Slams Forced DUI Blood Draw
5.'Multicultural Toilets' For 'Global Defecation' Seek to Stop Migrants Pooping On The Floor
6.Retired Cop Gets Taste Of Police State After Officers Bust In, Assault Him
7.Code 291: Swedish Police Cover-Up Thousands of Crimes Involving "Refugees"
8.NYPD Cop Wins $15m After Fellow Cops Falsely Arrested & Beat Him At His Daughter's Birthday
9.Crewe Residents Accuse Police and School of Covering Up Abuse, Rape Threats by Migrant Kids
10.NYPD Cop, Whose Job Was to Bust Prostitutes, Exposed as a Pimp in Massive Sex Trafficking Ring
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.